Evidence map›Paper›PMID 40964173›Full record

ReviewEXCLI journal2025

Polyphenols bind G4-Quadruplex structures and act as epigenetic modifiers with anti-cancer effects.

Marco Antonio Meraz-Rodriguez, Manuel Humberto Cháirez-Ramírez, Karen Griselda de la Cruz-López, Rubén Francisco González-Laredo, Alejandro García-Carrancá

Abstract readReview
In one paragraph

Review in EXCLI journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marco Antonio Meraz-RodriguezBiomedical Cancer Research Unit, Institute for Biomedical Research, National Autonomous University of Mexico (UNAM) & National Cancer Institute, Mexico City, Mexico (Unidad de Investigación Biomédica en Cáncer, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México & Instituto Nacional de Cancerología, Ciudad de México, México).
Manuel Humberto Cháirez-RamírezBiomedical Cancer Research Unit, Institute for Biomedical Research, National Autonomous University of Mexico (UNAM) & National Cancer Institute, Mexico City, Mexico (Unidad de Investigación Biomédica en Cáncer, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México & Instituto Nacional de Cancerología, Ciudad de México, México).
Karen Griselda de la Cruz-LópezBiomedical Cancer Research Unit, Institute for Biomedical Research, National Autonomous University of Mexico (UNAM) & National Cancer Institute, Mexico City, Mexico (Unidad de Investigación Biomédica en Cáncer, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México & Instituto Nacional de Cancerología, Ciudad de México, México).
Rubén Francisco González-LaredoNational Laboratory for the Evaluation of Biotic Products (LaNAEPBi), Service Unit, National Technological Institute of Mexico/Durango Institute of Technology, Functional Foods and Nutraceuticals Research Group, Durango, Mexico (Laboratorio Nacional de Apoyo a la Evaluación de Productos Bióticos (LaNAEPBi), Unidad de Servicio, Tecnológico Nacional de México/I.T. de Durango, Grupo de Investigación de Alimentos Funcionales y Nutracéuticos, Durango, México).
Alejandro García-CarrancáBiomedical Cancer Research Unit, Institute for Biomedical Research, National Autonomous University of Mexico (UNAM) & National Cancer Institute, Mexico City, Mexico (Unidad de Investigación Biomédica en Cáncer, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México & Instituto Nacional de Cancerología, Ciudad de México, México).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

G4-quadruplexes (G4s) are non-canonical structures of nucleic acids that develop in guanine rich regions of DNA and RNA. Due to their presence in oncogenic promoters and telomeres, G4s represent attractive targets in anticancer drug designs. G4s have also been the subject of recent research regarding their role as epigenetic modulators, supporting their participation in epigenetic processes that control gene expression. The development of small compounds that preferentially target G4s have led to a better understanding of how G4s control these mechanisms. Natural products have greatly contributed to the development of many successful examples of compounds with excellent anticancer activities. Therefore, it is important to investigate ligands targeting G4-quadruplexes in natural products such as dietary polyphenols and their derivatives. In this review, we provide an overview of the latest research on natural compounds, with especial emphasis on dietary polyphenols, as G4-quadruplex targeted ligands. We also discuss dietary polyphenols' structural chemistry that could facilitate their characterization as G4 ligands, highlighting their potential in the development of anticancer drugs. Finally, we explore polyphenols' potential mechanisms of action in regulating epigenetic machinery through G4 binding, thereby providing insights for the development of safe and effective therapeutical tools against cancer.

Indexed as

anti-cancer moleculesdietary polyphenolsepigenetic regulationG4 ligandsG4 quadruplexgene expression

Identifiers

PMID40964173
PMCPMC12436681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.